Centers for Medicare & Medicaid Services Added Six New Quality Measures to the Nursing Home Compare WebsiteOn April 27, 2016, the Centers for Medicare & Medicaid Services (CMS) added six [...]
What You Need to Know About Eliquis® (apixaban)Last month we reviewed Xarelto® (rivaroxaban) recommendations for use including indications, dosing guidelines, and administration pearls. This [...]
AlixaRx has successfully led a Kansas innovation pilot to gain the adoption of remote automated dispensing in long-term care facilities! Regulations have now been approved by the Kansas Board of [...]
A Guideline To Lipid Lowering AgentsTreatment guidelines for lowering cholesterol levels have recently been updated and recommendations for multi-drug regimens have decreased. In long-term care [...]
What You Need to Know About Duragesic (Fentanyl)Fentanyl (Duragesic) patches are often used in the long-term care setting for residents requiring around-the-clock pain management. Over the past [...]
From the Front Lines Appropriate Medication Use in Post-Acute and LTC From the Front Lines is a monthly publication of AlixaRx Pharmacy that shares best practices and medication-related [...]
Update on Repatha (Evolocumab) - a Medication Used to Treat High Low Density Lipoprotein CholesterolApproved by the FDA in August 2015, Repatha (Evolocumab) is a subcutaneous injection used to [...]
FDA Recommends Restricting the Use of Fluoroquinolones Due to Potential Side EffectsThe FDA has recently released a statement indicating that the use of systemic fluoroquinolones should be [...]
AlixaRx Makes Enhancements to Therapeutic Interchange ProgramAlixaRx is pleased to announce that we have expanded our Therapeutic Interchange (TI) program. This program allows prescribers to [...]
From the Front Lines Appropriate Medication Use in Post-Acute and LTC From the Front Lines is a monthly publication of AlixaRx Pharmacy that shares best practices and medication-related [...]
